Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis
Elena Masselli(University of Parma), Marco Vitale(Vita-Salute San Raffaele University), Vittorio Rosti(Istituti di Ricovero e Cura a Carattere Scientifico), Laura Villani(Istituti di Ricovero e Cura a Carattere Scientifico), Margherita Massa(Policlinico San Matteo Fondazione), Giulia Pozzi(University of Parma), Antonio Percesepe(University of Parma), Sabrina Bonomini(Ospedale di Parma), Giovanni Roti(University of Parma), Rita Campanelli(Istituti di Ricovero e Cura a Carattere Scientifico), Cecilia Carubbi(University of Parma), Giovanni Barosi(Policlinico San Matteo Fondazione), Giuliana Gobbi(University of Parma)
Cited by 14
Related Papers
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
|Oncotarget|2018|522
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461